Under 40 years
- 12 Dec 2023
- 1 Minute to read
- Print
- PDF
Under 40 years
- Updated on 12 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
NICE says diagnose premature ovarian insufficiency (POI) based on:
- Age <40 years.
- Menopause symptoms including no or infrequent periods (consider whether the person has had a hysterectomy).
- Elevated FSH levels (>30IU/L) on two blood samples taken 4–6 weeks apart. If there are still periods, these blood tests should be taken on day 2-3 of the cycle.
- Do not diagnose POI on a single blood test.
- Additional testing of serum LH, estradiol, prolactin, testosterone and TSH levels may be helpful for the diagnostic workup.
- Do not routinely use anti-Müllerian hormone to diagnose POI.
- Consider the woman’s history, for example, previous medical, surgical or family history when diagnosing POI.
NICE states FSH levels should not be checked in a woman using HRT, combined contraception or a high dose progestogen. For more information see section use of FSH levels.
NOTE:
- Diagnosis can be more difficult in women using hormone treatments or in women with a prior history of endometrial ablation or hysterectomy. These women will have altered or absent bleed patterns. For more information see flowchart in: The 2023 Practitioners Toolkit for Managing Menopause on page 7.
- If in doubt, refer to a menopause specialist.
References and Further Information:
- National Institute for Health and Care Excellence. Guideline. Menopause (update). Draft for consultation, Nov 2023.
- NICE CKS guidance. Diagnosis. Diagnosis of premature ovarian insufficiency. Last revised September 2022.
- NICE Menopause: diagnosis and management. Section 1.2.4. Diagnosing and managing premature ovarian insufficiency. Last updated December 2019.
- Panay N, Anderson A, Nappi R et al. Premature ovarian insufficiency: an International Menopause White Paper. Climacteric. 2020.
- Menopause Practice Standards produced by the British Menopause Society (BMS), Royal College of Obstetricians and Gynaecologists (RCOG), Society for Endocrinology (SfE), Faculty of Sexual and Reproductive Health (FSRH), Faculty of Pharmaceutical Medicine (FPM) and Royal Pharmaceutical Society (RPS) 2022.
Was this article helpful?